535 related articles for article (PubMed ID: 10737616)
1. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta.
Reynolds CH; Betts JC; Blackstock WP; Nebreda AR; Anderton BH
J Neurochem; 2000 Apr; 74(4):1587-95. PubMed ID: 10737616
[TBL] [Abstract][Full Text] [Related]
2. Sites of phosphorylation in tau and factors affecting their regulation.
Anderton BH; Betts J; Blackstock WP; Brion JP; Chapman S; Connell J; Dayanandan R; Gallo JM; Gibb G; Hanger DP; Hutton M; Kardalinou E; Leroy K; Lovestone S; Mack T; Reynolds CH; Van Slegtenhorst M
Biochem Soc Symp; 2001; (67):73-80. PubMed ID: 11447841
[TBL] [Abstract][Full Text] [Related]
3. Reactivating kinase/p38 phosphorylates tau protein in vitro.
Reynolds CH; Nebreda AR; Gibb GM; Utton MA; Anderton BH
J Neurochem; 1997 Jul; 69(1):191-8. PubMed ID: 9202310
[TBL] [Abstract][Full Text] [Related]
4. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation.
Zheng-Fischhöfer Q; Biernat J; Mandelkow EM; Illenberger S; Godemann R; Mandelkow E
Eur J Biochem; 1998 Mar; 252(3):542-52. PubMed ID: 9546672
[TBL] [Abstract][Full Text] [Related]
5. tau kinases in the rat heat shock model: possible implications for Alzheimer disease.
Shanavas A; Papasozomenos SC
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14139-44. PubMed ID: 11121021
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
Lovestone S; Reynolds CH; Latimer D; Davis DR; Anderton BH; Gallo JM; Hanger D; Mulot S; Marquardt B; Stabel S
Curr Biol; 1994 Dec; 4(12):1077-86. PubMed ID: 7704571
[TBL] [Abstract][Full Text] [Related]
7. Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase.
Mudher A; Chapman S; Richardson J; Asuni A; Gibb G; Pollard C; Killick R; Iqbal T; Raymond L; Varndell I; Sheppard P; Makoff A; Gower E; Soden PE; Lewis P; Murphy M; Golde TE; Rupniak HT; Anderton BH; Lovestone S
J Neurosci; 2001 Jul; 21(14):4987-95. PubMed ID: 11438574
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK).
Yoshida H; Hastie CJ; McLauchlan H; Cohen P; Goedert M
J Neurochem; 2004 Jul; 90(2):352-8. PubMed ID: 15228592
[TBL] [Abstract][Full Text] [Related]
9. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons.
Takashima A; Honda T; Yasutake K; Michel G; Murayama O; Murayama M; Ishiguro K; Yamaguchi H
Neurosci Res; 1998 Aug; 31(4):317-23. PubMed ID: 9809590
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase FA/glycogen synthase kinase-3 alpha after heparin potentiation phosphorylates tau on sites abnormally phosphorylated in Alzheimer's disease brain.
Yang SD; Yu JS; Shiah SG; Huang JJ
J Neurochem; 1994 Oct; 63(4):1416-25. PubMed ID: 7931292
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
12. Stress-activated protein kinase/c-jun N-terminal kinase phosphorylates tau protein.
Reynolds CH; Utton MA; Gibb GM; Yates A; Anderton BH
J Neurochem; 1997 Apr; 68(4):1736-44. PubMed ID: 9084448
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.
Ferrer I; Barrachina M; Tolnay M; Rey MJ; Vidal N; Carmona M; Blanco R; Puig B
Brain Pathol; 2003 Jan; 13(1):62-78. PubMed ID: 12580546
[TBL] [Abstract][Full Text] [Related]
14. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
[TBL] [Abstract][Full Text] [Related]
15. Tau therapeutic strategies for the treatment of Alzheimer's disease.
Churcher I
Curr Top Med Chem; 2006; 6(6):579-95. PubMed ID: 16712493
[TBL] [Abstract][Full Text] [Related]
16. Identification of genomic organisation, sequence variants and analysis of the role of the human dishevelled 1 gene in late onset Alzheimer's disease.
Russ C; Lovestone S; Powell JF
Mol Psychiatry; 2002; 7(1):104-9. PubMed ID: 11803455
[TBL] [Abstract][Full Text] [Related]
17. Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3 beta but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of tau: implications for Alzheimer's disease.
Papasozomenos SCh; Shanavas A
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1140-5. PubMed ID: 11805297
[TBL] [Abstract][Full Text] [Related]
18. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
[TBL] [Abstract][Full Text] [Related]
19. Nav1.7-Ca2+ influx-induced increased phosphorylations of extracellular signal-regulated kinase (ERK) and p38 attenuate tau phosphorylation via glycogen synthase kinase-3beta: priming of Nav1.7 gating by ERK and p38.
Nemoto T; Miyazaki S; Kanai T; Maruta T; Satoh S; Yoshikawa N; Yanagita T; Wada A
Eur J Pharmacol; 2010 Aug; 640(1-3):20-8. PubMed ID: 20470771
[TBL] [Abstract][Full Text] [Related]
20. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
